Ireland· IE-PA-EU/1/96/004/002
Fareston 60 mg Tablets
A toremifene product containing toremifene, registered in Ireland by Orion Corporation. The same ATC class is registered in 12 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Toremifene is registered in 12 of 19 countries.
Countries holding a registration under ATC L02BA02 (toremifene), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 8 of them publish a price we can compare per daily dose
Toremifene · ATC L02BA02
12 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Polandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of toremifene costs, country by country.
Normalised to the WHO defined daily dose (60 mg), so markets compare like for like.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Toremifene · price per daily dose (60 mg)
USD · FX 28 Sept 2026
- IT Italy$1.17
- FR France$0.94
The record
At a glance
HPRA (Ireland)- Active substance
- Toremifene
- Manufacturer
- Orion Corporation
- Country
- Ireland (IE)
- ATC code
- L02BA02
- ATC class
- Toremifene
- Defined daily dose
- 60 mg, O
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/96/004/002
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
460 interactions on record for toremifene.
Graded by severity as the source publishes them — 279 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Toremifene · interactions on record
460 records
- 279 severe
- 133 moderate
- 3 minor
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- OndansetronA04AA01severe
- GranisetronA04AA02severe
45 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Toremifene in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumFareston 60 mgOrion
- FinlandFarestonOrion Corporation
- United StatesFarestonKyowa Kirin, Inc.
- CzechiaFARESTONOrion Corporation, Espoo
- United KingdomFareston 60mg tabletsOrion Pharma (UK) Ltd
- SpainFARESTON 60 mg COMPRIMIDOSOrion Corporation
- NetherlandsFareston, tabletten 60 mgOrion Corporation
- PolandFarestonOrion Corporation
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Fareston
- Liechtenstein · Fareston
- Norway · Fareston
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/35334849-eefb-4d89-a57d-51877cfa72d6 GET /v1/drugs/35334849-eefb-4d89-a57d-51877cfa72d6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablet",
"routes": null,
"source": "hpra",
"atc_all": [
"L02BA",
"L02BA02"
],
"strength": null,
"pa_number": "EU/1/96/004/002",
"substances": [
"Toremifene"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "14/02/1996",
"dispensing_status": "Product subject to prescription which may be renewed (B)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about toremifene.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.